Anavex Life Sciences Corp. (AVXL) Balance Sheet
AVXL balance sheet, FY2025
September 30, 2025 · U.S. dollars$103.8M assets = $8.9M liabilities + $94.9M equity
Both columns are drawn to the same scale: what AVXL owns equals what it owes plus shareholders’ equity. Hover a block for its value.
AVXL financial health
Descriptive bands, not a rating. Fiscal FY2025.
AVXL balance sheet trends, FY2016–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $9.5MFY2016 | $103.8MFY2025 | +30.4%/yr | |
| Total liabilities | $3.2MFY2016 | $8.9MFY2025 | +12.1%/yr | |
| Shareholders’ equity | $6.3MFY2016 | $94.9MFY2025 | +35.1%/yr | |
| Cash & short-term investments | $9.2MFY2016 | $102.6MFY2025 | +30.7%/yr | |
| Working capital | $6.3MFY2016 | $94.9MFY2025 | +$88.6M | |
| Book value per share | $0.18FY2016 | $1.11FY2025 | +22.5%/yr | |
| Shares outstanding | 35.2MFY2016 | 85.3MFY2025 | +10.3%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
AVXL assets
AVXL liabilities and equity
AVXL debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
AVXL balance sheet
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $102.6M | $132.2M | $151.0M | $149.2M | $152.1M | $29.2M | $22.2M | $22.9M | $27.4M | $9.2M |
| Cash & equivalents | $102.6M | $132.2M | $151.0M | $149.2M | $152.1M | $29.2M | $22.2M | $22.9M | $27.4M | $9.2M |
| Short-term investments | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Receivables | $809,000 | $2.4M | $2.7M | $3.2M | $9.1M | $4.8M | $2.6M | $1.9M | $9,748 | $79,347 |
| Inventory | $0 | $0 | $0 | $0 | $16,365 | $0 | −$2.6M | $0 | $0 | $0 |
| Other current assets | $429,000 | $931,000 | $653,000 | $353,742 | $355,549 | $443,839 | $3.1M | $0 | $335,928 | $180,124 |
| Total current assets | $103.8M | $135.6M | $154.4M | $152.7M | $161.6M | $34.5M | $25.3M | $24.3M | $27.8M | $9.4M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $52,396 | $52,396 | $52,396 |
| Total assets | $103.8M | $135.6M | $154.4M | $152.7M | $161.6M | $34.5M | $25.3M | $24.4M | $27.8M | $9.5M |
| Liabilities | ||||||||||
| Accounts payable | $4.2M | $9.6M | $4.3M | $3.8M | $4.7M | $4.0M | $3.5M | $3.0M | $3.6M | $3.1M |
| Deferred revenue | $805,000 | $842,000 | $917,000 | $443,831 | $443,831 | — | — | — | — | $70,532 |
| Total current liabilities | $8.9M | $15.3M | $12.5M | $10.2M | $10.8M | $7.3M | $5.0M | $3.9M | $3.6M | $3.2M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $3.9M | $4.8M | $7.3M | $4.3M | $0 | $3.3M | $1.5M | $0 | $0 | $0 |
| Total liabilities | $8.9M | $15.3M | $12.5M | $10.2M | $10.8M | $7.3M | $5.0M | $3.9M | $3.6M | $3.2M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $87,000 | $85,000 | $82,000 | $77,944 | $75,920 | $62,047 | $52,652 | $45,935 | $43,332 | $36,169 |
| Retained earnings (deficit) | −$382.4M | −$336.1M | −$293.1M | −$245.6M | −$197.6M | −$159.7M | −$133.4M | −$108.9M | −$91.5M | −$78.0M |
| Treasury stock | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Accumulated other comprehensive income | — | — | $0 | $0 | $0 | — | — | $0 | $0 | $0 |
| Minority interest | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Total shareholders' equity | $94.9M | $120.3M | $141.9M | $142.5M | $150.8M | $27.2M | $20.3M | $20.5M | $24.3M | $6.3M |
| Key figures | ||||||||||
| Working capital | $94.9M | $120.3M | $141.9M | $142.5M | $150.8M | $27.2M | $20.3M | $20.4M | $24.2M | $6.3M |
| Tangible book value | $94.9M | $120.3M | $141.9M | $142.5M | $150.8M | $27.2M | $20.3M | $20.5M | $24.3M | $6.3M |
| Book value per share | $1.11 | $1.44 | $1.78 | $1.85 | $2.16 | $0.47 | $0.41 | $0.46 | $0.59 | $0.18 |
| Shares outstanding | 85.3M | 83.5M | 79.8M | 76.9M | 69.8M | 58.2M | 48.9M | 44.7M | 40.8M | 35.2M |
| Current ratio | 11.60 | 8.86 | 12.32 | 14.95 | 14.97 | 4.73 | 5.03 | 6.26 | 7.75 | 2.96 |
| Quick ratio | 11.56 | 8.80 | 12.27 | 14.92 | 14.93 | 4.67 | 4.93 | 6.38 | 7.66 | 2.90 |
| Equity / assets | 91.4% | 88.7% | 91.9% | 93.3% | 93.3% | 78.9% | 80.1% | 84.1% | 87.1% | 66.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $118.3M | $127.4M | $131.7M | $102.6M | $101.2M | $115.8M | $120.8M | $132.2M | $138.8M | $139.4M | $143.8M | $151.0M |
| Cash & equivalents | $118.3M | $127.4M | $131.7M | $102.6M | $101.2M | $115.8M | $120.8M | $132.2M | $138.8M | $139.4M | $143.8M | $151.0M |
| Receivables | $995,000 | $932,000 | $844,000 | $809,000 | $820,000 | $666,000 | $2.6M | $2.4M | $1.7M | $3.8M | $3.5M | $2.7M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $818,000 | $411,999 | $396,000 | $429,000 | $0 | $702,000 | $711,000 | $931,000 | $1.1M | $1.3M | $756,000 | $653,000 |
| Total current assets | $120.1M | $128.8M | $133.0M | $103.8M | $101.2M | $117.1M | $124.0M | $135.6M | $141.5M | $144.5M | $148.1M | $154.4M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $1.3M | $0 | $0 | $0 | $0 | $234,000 | $0 | $0 |
| Total assets | $120.1M | $128.8M | $133.0M | $103.8M | $102.4M | $117.1M | $124.0M | $135.6M | $141.5M | $144.8M | $148.1M | $154.4M |
| Liabilities | ||||||||||||
| Accounts payable | $3.7M | $2.5M | $2.6M | $4.2M | $6.7M | $7.0M | $4.6M | $9.6M | $3.5M | $3.7M | $4.3M | $4.3M |
| Short-term debt | — | — | — | — | — | — | — | — | −$917,000 | $917,000 | — | — |
| Deferred revenue | — | $805,000 | $805,000 | $805,000 | $805,000 | $829,000 | $829,000 | $842,000 | $917,000 | $917,000 | $917,000 | $917,000 |
| Total current liabilities | $7.7M | $7.1M | $6.4M | $8.9M | $11.5M | $17.4M | $13.1M | $15.3M | $11.8M | $9.6M | $12.5M | $12.5M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $4.0M | $0 | $2.9M | $3.9M | $3.9M | $9.6M | $7.7M | $4.8M | $7.3M | $4.9M | $7.3M | $7.3M |
| Total liabilities | $7.7M | $7.1M | $6.4M | $8.9M | $11.5M | $17.4M | $13.1M | $15.3M | $11.8M | $9.6M | $12.5M | $12.5M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $93,000 | $93,000 | $93,000 | $87,000 | $85,000 | $85,000 | $85,000 | $85,000 | $85,000 | $84,000 | $82,000 | $82,000 |
| Retained earnings (deficit) | −$385.6M | −$393.5M | −$388.1M | −$382.4M | −$372.6M | −$359.4M | −$348.2M | −$336.1M | −$324.5M | −$312.2M | −$301.7M | −$293.1M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | −$89,000 | −$234,000 | $0 | $0 |
| Total shareholders' equity | $112.4M | $121.7M | $126.6M | $94.9M | $91.0M | $99.8M | $110.9M | $120.3M | $129.8M | $135.2M | $135.6M | $141.9M |
| Key figures | ||||||||||||
| Total debt | — | — | — | — | — | — | — | — | −$917,000 | $917,000 | — | — |
| Net cash (debt) | — | — | — | — | — | — | — | — | $139.7M | $138.5M | — | — |
| Working capital | $112.4M | $121.7M | $126.6M | $94.9M | $89.7M | $99.8M | $110.9M | $120.3M | $129.8M | $135.0M | $135.6M | $141.9M |
| Tangible book value | $112.4M | $121.7M | $126.6M | $94.9M | $91.0M | $99.8M | $110.9M | $120.3M | $129.8M | $135.2M | $135.6M | $141.9M |
| Book value per share | $1.23 | $1.31 | $1.42 | $1.10 | $1.07 | $1.17 | $1.31 | $1.43 | $1.54 | $1.64 | $1.65 | $1.78 |
| Shares outstanding | 91.5M | 92.7M | 89.0M | 85.9M | 85.4M | 85.1M | 84.8M | 84.0M | 84.5M | 82.5M | 82.1M | 79.8M |
| Current ratio | 15.62 | 18.24 | 20.87 | 11.60 | 8.82 | 6.74 | 9.45 | 8.86 | 12.04 | 15.12 | 11.85 | 12.32 |
| Quick ratio | 15.51 | 18.18 | 20.81 | 11.56 | 8.89 | 6.70 | 9.39 | 8.80 | 11.95 | 14.98 | 11.79 | 12.27 |
| Debt / equity | — | — | — | — | — | — | — | — | −0.01 | 0.01 | — | — |
| Equity / assets | 93.6% | 94.5% | 95.2% | 91.4% | 88.8% | 85.2% | 89.4% | 88.7% | 91.7% | 93.4% | 91.6% | 91.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed November 25, 2025); data from EODHD.
AVXL financial position
At the end of fiscal 2025 (September 30, 2025), Anavex Life Sciences had total assets of $103.8 million (down 23.4% from a year earlier), total liabilities of $8.9 million and shareholders' equity of $94.9 million. Its current ratio was 11.60. In the latest quarter (ended June 30, 2026) total assets were $120.1 million and equity $112.4 million.
Related: AVXL income statement, AVXL cash flow statement, AVXL key metrics. See the AVXL stock overview for the latest quote and news.
AVXL balance sheet FAQ
What are Anavex Life Sciences's total assets?
Anavex Life Sciences reported total assets of $103.8 million at the end of fiscal 2025 (September 30, 2025), compared with $135.6 million a year earlier.
How much cash does Anavex Life Sciences have?
Anavex Life Sciences held $102.6 million in cash and short-term investments at the end of fiscal 2025.
What is Anavex Life Sciences's book value?
Anavex Life Sciences's shareholders' equity (book value) was $94.9 million at the end of fiscal 2025, or $1.11 per share.
What is Anavex Life Sciences's current ratio?
Anavex Life Sciences had current assets of $103.8 million and current liabilities of $8.9 million, a current ratio of 11.60 (it can cover its short-term obligations).